LONDON BROKER RATINGS: UBS cuts Diageo; Goldman Sachs cuts NatWest
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
| Price | 328.50p on 19-12-2025 at 06:00:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Sell 3,779.00 at 328.50p |
| Day's Volume: | 0 |
| Last Close: | 328.50p |
| Open: | 0.00p |
| ISIN: | GB00BKRC5K31 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 293.00p - 423.00p |
| Market Capitalisation: | £816.52m |
| VWAP: | 0.00p |
| Shares in Issue: | 248.56m |
Genuit Group (GEN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,779 | 328.50p | Automatic Execution |
16:37:00 - 18-Dec-25 |
| Sell* | 33 | 328.50p | Automatic Execution |
16:37:00 - 18-Dec-25 |
| Sell* | 73 | 328.50p | Automatic Execution |
16:35:27 - 18-Dec-25 |
| Sell* | 3,279 | 328.50p | SI Trade |
16:35:22 - 18-Dec-25 |
| Sell* | 153,896 | 328.50p | Uncrossing Trade |
16:35:22 - 18-Dec-25 |
| Sell* | 107 | 328.50p | Automatic Execution |
16:29:50 - 18-Dec-25 |
| Sell* | 100 | 328.50p | Automatic Execution |
16:29:50 - 18-Dec-25 |
| Buy* | 169 | 328.50p | Automatic Execution |
16:29:42 - 18-Dec-25 |
| Buy* | 158 | 328.50p | Automatic Execution |
16:29:40 - 18-Dec-25 |
| Buy* | 851 | 328.50p | Automatic Execution |
16:29:40 - 18-Dec-25 |
Genuit Group (GEN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Dec 2025 2:03 pm | RNS | Holding(s) in Company |
| 16th Dec 2025 2:01 pm | RNS | Holding(s) in Company |
| 12th Dec 2025 3:41 pm | RNS | Director/PDMR Shareholding |
| 10th Dec 2025 4:11 pm | RNS | Director/PDMR Shareholding |
| 9th Dec 2025 10:44 am | RNS | Holding(s) in Company |
| 3rd Dec 2025 5:11 pm | RNS | Holding(s) in Company |
| 3rd Dec 2025 4:56 pm | RNS | Director/PDMR Shareholding |
| 3rd Dec 2025 4:39 pm | RNS | Director/PDMR Shareholding |
| 3rd Dec 2025 10:00 am | RNS | Holding(s) in Company |
| 2nd Dec 2025 5:09 pm | RNS | Holding(s) in Company |